In the last few years, a great interest has emerged in investigating the pleiotropic effects of
Glucagon Like Peptide-1 Receptor Agonists (GLP-1RAs). While GLP-1RAs ability to lower …

Adipose tissue is a complex dynamic organ with whole-body immunometabolic influence.
Much of the work into understanding the role of immune cells in adipose tissue has been in …

Adipose tissue macrophage (ATM) has been appreciated for its critical contribution to
obesity-associated metabolic diseases in recent years. Here, we discuss the regulation of …

Glucose is a vital source of energy for all mammals. The balance between glucose uptake,
metabolism and storage determines the energy status of an individual, and perturbations in …

Over the past decades, the relationship between the immune system and metabolism has
become a major research focus. In this arena of immunometabolism the capacity of adipose …

The expansion of adipose tissue is an adaptive mechanism that increases nutrient buffering
capacity in response to an overall positive energy balance. Over the course of expansion …

Abstract Purpose The majority of Polycystic ovary syndrome (PCOS) are overweight or
obese with increased infertility and high risk of pregnancy complications. We aim to compare …

Obesity, a growing chronic metabolic disease, greatly increases the risk of metabolic
syndrome which includes type 2 diabetes, fatty liver and cardiovascular diseases. Obesity …

Aims Liraglutide is a long-acting glucagon-like peptide 1 (GLP-1) receptor agonist used as
an anti-hyperglycemic agent in type 2 diabetes treatment and recently approved for obesity …

Research focusing on adipose immunometabolism has been expanded from inflammation
in white fat during obesity development to immune cell function regulating thermogenic fat …